Liminatus Pharma Inc. (LIMN) vs Heatwurx Inc. (PCSA)

Liminatus Pharma Inc. and Heatwurx Inc. are both Biotechnology companies. Liminatus Pharma Inc. and Heatwurx Inc. are of similar size ($5.6M and $5.2M). Liminatus Pharma Inc. has negative trailing earnings, so its P/E is not meaningful; Heatwurx Inc. trades at 1.8×. Across the 8 metrics below, Liminatus Pharma Inc. leads on 4 and Heatwurx Inc. on 4.

Valuation

Metric LIMN PCSA Biotechnology median
P/E n/m 1.75 7.88
P/S n/m 38.64 11.47
P/B 13.53 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 38.45 10.73
Earnings yield (559.52%) 57.14% (28.84%)
Free cash flow yield (97.71%) (259.68%) (23.03%)

Profitability

Metric LIMN PCSA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 294.43% (464.19%) (57.72%)
Return on assets (471.47%) (262.17%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LIMN PCSA Biotechnology median
Revenue growth (TTM) — (34.50%) 5.64%
EPS growth (last fiscal year) (112.19%) 89.29% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LIMN PCSA Biotechnology median
Debt to equity 4.80 0.00 0.00
Current ratio 1.12 0.87 4.73
Net debt to EBITDA (0.37) 0.40 0.96

Dividend

Metric LIMN PCSA Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric LIMN PCSA Biotechnology median
Market cap 5.61m 5.17m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack